Page 44 - ebook
P. 44

[B. Cell Biology/Stem Cell] B-22



              Ginsenoside protopanaxadiol-induced changes in autophagy


              and apoptosis in chloroquine-induced adult retinal pigment


                                               epithelial-19 cells




                          Haesung Lee¹, Long Ngo Hoang¹, Ngoc Buu Tran¹, Sook-Jeong Lee¹*

             ¹Department of Bioactive Material Sciences and Research Center of Bioactive Materials, Jeonbuk National

                                        University, Jeonju, Jeollabuk-do 54896, Korea




        Ginsenosides are the major active component found in ginseng (Panax ginseng). Among the ginsenosides, (20S)-

        Protopanaxadiol (PPD) ginsenosides Rg3, Rh2 have been demonstrated for their hepatoprotection, tumor
        suppression and diabetes resistance. Chloroquine (CQ) is an antimalarial drug known to inhibit autophagy flux by

        impairing autophagosome–lysosome fusion, frequently causes serious eye and vision problems. In this study, we
        dertermined whether the PPD reduces CQ-induced retinopathy by restoring lysosomotropic abnormalities in human

        adult  retinal  pigment  epithelial  (ARPE)-19  cells.  The  accumulation  of  autophagosomes  with  fusion  defects  in
        lysosomes and the formation of ROS in CQ-treated ARPE-19 cells, which trapped Beclin-1 with B-cell lymphoma 2

        (Bcl-2),  interfering  with  autophagy  initiation  and  autophagosome  development.  PPD  alleviated  the  CQ-induced
        toxicity by modulating the interaction between Beclin-1 and Bcl-2, and this effect was mediated by the 5' adenosine
        monophosphate-activated  protein  kinase-mammalian  target  of  rapamycin  signal  axis.  The  results  indicate  that

        autophagy  and  apoptosis  were  simultaneously  controlled  by  PPD  via  the  upregulation  of  autophagy  flux  and

        decreased ROS formation and apoptotic protein expression. These findings suggest that PPD may be a promising
        treatment strategy for CQ-mediated retinopathy.
   39   40   41   42   43   44   45   46   47   48   49